Reversing Preeclampsia Pathology: AXL Inhibition Restores Mitochondrial Function and ECM Balance
Preeclampsia (PE) is a leading cause of maternal and fetal morbidity that affects 2–8% of pregnancies worldwide, driven by placental dysfunction and systemic inflammation. Growth arrest-specific protein 6 (Gas6) and its receptor AXL play pivotal roles in PE pathogenesis, promoting trophoblast impair...
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2025-08-01
|
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2073-4409/14/16/1229 |
